Green Cross Medical Science Registered Executive Kim Won-gi Increases Stake via Open Market Purchase; Outstanding Shares Rise 9.3% from Stock Option Exercise

Green Cross Medical Science registered executive Kim Won-gi acquired 3,000 common shares via open market purchase at 3,058 KRW per share on June 26, 2026, increasing his holdings to 4,000 shares, representing a mere 0.02% stake.
The report reveals that since the prior filing, the exercise of stock options increased total outstanding shares by 2,221,105 shares, resulting in a 9.3% dilution for existing shareholders.
The insider's small share purchase signals management confidence but has limited price impact due to the minimal stake.
[AI Summary]While the insider purchase is a positive governance signal, the negligible scale and the concurrent 9.3% dilution from option exercises present a net neutral risk. Investors should monitor further dilution potential.